Aspire-Lakewood Holdings, Inc.

ASBPW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
Assets
Cash & Equivalents $1.0M $3.6K $11.2K $497.3K —
Accounts Receivable — — — — —
Inventory $253.2K — — — —
Total Current Assets $1.3M $148.0K $81.2K $1.1M $293.2K
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Intangible Assets (Excl. Goodwill) — — — — —
Total Assets $1.3M $148.0K $20.0M $300.2M $293.2K
Liabilities
Accounts Payable $1.0M $310.2K — — —
Total Current Liabilities $7.6M $1.7M $403.3K $303.3K $293.7K
Long-Term Debt — — — — —
Total Liabilities $7.7M $1.7M $403.3K $11.1M $293.7K
Stockholders' Equity
Retained Earnings $-27.3M $-2.8M $-11.3M $-9.9M $-25.5K
Total Stockholders' Equity $-6.4M $-1.5M $-487.9K $-9.9M $-475